These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2561183)

  • 1. Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():14-34. PubMed ID: 2561183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
    Odds FC
    J Dermatol Sci; 1993 Apr; 5(2):65-72. PubMed ID: 8395201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycotic activity of BAY N 7133 in animal experiments.
    Plempel M
    J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
    Schaude M; Petranyi G; Ackerbauer H; Meingassner JG; Mieth H
    J Med Vet Mycol; 1990; 28(6):445-54. PubMed ID: 2093117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic vulvovaginal candidosis: the role of oral treatment.
    Merkus JM; Van Heusden AM
    Br J Clin Pract Suppl; 1990 Sep; 71():81-4. PubMed ID: 1965421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itraconazole in the treatment of human mycoses: review of three years of clinical experience.
    Cauwenbergh G; De Doncker P; Stoops K; De Dier AM; Goyvaerts H; Schuermans V
    Rev Infect Dis; 1987; 9 Suppl 1():S146-52. PubMed ID: 3027842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European experience with itraconazole in systemic mycoses.
    Viviani MA; Tortorano AM; Pagano A; Vigevani GM; Gubertini G; Cristina S; Assaisso ML; Suter F; Farina C; Minetti B
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):587-93. PubMed ID: 2170478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of experimental meningeal and disseminated cryptococcosis.
    Van Cutsem J
    Mycoses; 1993; 36(11-12):357-67. PubMed ID: 7935566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy for systemic mycosis.
    Polak A
    Infection; 1989; 17(4):203-9. PubMed ID: 2548963
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.